Rachel has worked in clinical research for over 8 years and is currently a Senior Project Manager for The CLINICAL TRIAL CompanyTM (TCTC). Rachel’s research career started in 2011 with GlaxoSmithKline as a Clinical Research Scientist (Study Manager) before moving to Scope International UK and then TCTC in 2015. Rachel achieved Silver award at the International Clinical Researcher of the Year Awards in 2016.
Rachel has worked across all clinical phases (I-IV) with a focus on complex advanced therapy trials, working closely with innovative biopharma across different therapeutic areas. Rachel is currently the project director of a portfolio of paediatric gene therapy studies in rare diseases across the US and Europe.
Rachel has a BSc (Hons) Biochemistry from the University of Warwick, is a Registered Member of the Institute of Clinical Research, and has been published in the European Journal of Drug Metabolism and Pharmacokinetics and Lambert Academic publishing.
The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.